Join

Compare · MOH vs MSON

MOH vs MSON

Side-by-side comparison of Molina Healthcare Inc (MOH) and MISONIX, Inc. (MSON): market cap, price performance, sector, and recent activity on the wire.

Summary

  • MOH operates in Health Care, while MSON operates in Capital Goods - the two are in different parts of the market.
  • MOH is the larger of the two at $9.16B, about 19.8x MSON ($462.5M).
  • MOH has hit the wire 3 times in the past 4 weeks while MSON has been quiet.
  • MOH has more recent analyst coverage (25 ratings vs 2 for MSON).
MetricMOHMSON
Company
Molina Healthcare Inc
MISONIX, Inc.
Price
$175.91+0.84%
$26.23+3.72%
Market cap
$9.16B
$462.5M
1M return
+25.82%
-
1Y return
-45.10%
-
Industry
Medical Specialities
Medical Specialities
Exchange
NYSE
NASDAQ
IPO
2003
1992
News (4w)
3
0
Recent ratings
25
2
MOH

Molina Healthcare Inc

Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. The company operates in two segments, Health Plans and Other. As of December 31, 2020, it served approximately 4.0 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 15 states. The company offers its health care services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies. Molina Healthcare, Inc. was founded in 1980 and is headquartered in Long Beach, California.

MSON

MISONIX, Inc.

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Latest MOH

Latest MSON